---
title: GMP Ancillary Materials for Cell and Gene Therapy Manufacturing
---

WEBINAR

# GMP Ancillary Materials for Cell and Gene Therapy Manufacturing

WATCH NOW

![WebinarsBY-TN-White](https://go.technologynetworks.com/hubfs/WebinarsBY-TN-White.png "WebinarsBY-TN-White")

 

 

### Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.

 [Read More Below](https://go.technologynetworks.com/gmp-ancillary-materials-for-cell-and-gene-therapy-manufacturing#webinar-summary)

![Thermo logo](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/Landing%20Pages/Thermo/Thermo%20logo.png?width=350&name=Thermo%20logo.png "Thermo logo")

### Webinar Summary:

Ancillary materials (AMs), also called raw materials in Europe, are components, reagents, and materials used in the manufacturing of cell, gene, and tissue-engineered (CGT) therapies but are not intended to be present in the final product formulation. AMs include, but are not limited to, cell culture reagents and additives (e.g. transfection reagents and antibiotics), cryopreservation agents, and disposables such as plasticware and bioprocessing bags. While ancillary materials are not intended to be detectable in the final therapeutic, their presence in the manufacturing process may affect the final drug's safety, efficacy, stability and consistency. Therefore, it is critical for CGT therapy manufacturers to carefully define the selection criteria and subsequent qualification program for AMs.

**Watch now to learn about:**

- What is a GMP Ancillary material and the associated regulatory challenges?
- Key raw material considerations when choosing suppliers 
- Importance and impact of raw material selection for commercial manufacture 

**Speaker Information:**

![Kime](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/Landing%20Pages/Thermo/Mariskka/Cell%20Therapy/Kime.png?width=128&name=Kime.png)

**Kasey Kime **  
Senior Manager, Regulatory Affairs 

![roos](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/Landing%20Pages/Thermo/Mariskka/Cell%20Therapy/roos.png?width=128&name=roos.png)

**Eric Roos**  
Strategic Alliance Manager

[![Share on Facebook](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/FB.png?width=24&name=FB.png)](http://www.facebook.com/share.php?u=https%3A%2F%2Fgo.technologynetworks.com%2Fgmp-ancillary-materials-for-cell-and-gene-therapy-manufacturing%3Futm_medium%3Dsocial%26utm_source%3Dfacebook) [![Share on LinkedIn](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/linkedIn.png?width=24&name=linkedIn.png)](http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fgo.technologynetworks.com%2Fgmp-ancillary-materials-for-cell-and-gene-therapy-manufacturing%3Futm_medium%3Dsocial%26utm_source%3Dlinkedin) [![Share on Twitter](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/Twitter.png?width=24&name=Twitter.png)](https://twitter.com/intent/tweet?original_referer=https%3A%2F%2Fgo.technologynetworks.com%2Fgmp-ancillary-materials-for-cell-and-gene-therapy-manufacturing%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&url=https%3A%2F%2Fgo.technologynetworks.com%2Fgmp-ancillary-materials-for-cell-and-gene-therapy-manufacturing%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&source=tweetbutton&text=GMP%20Ancillary%20Materials%20for%20Cell%20and%20Gene%20Therapy%20Manufacturing) [![Share on Email](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/email.png?width=24&name=email.png)](mailto:?subject=Check%20out%20https%3A%2F%2Fgo.technologynetworks.com%2Fgmp-ancillary-materials-for-cell-and-gene-therapy-manufacturing%3Futm_medium%3Dsocial%26utm_source%3Demail%20&body=Check%20out%20https%3A%2F%2Fgo.technologynetworks.com%2Fgmp-ancillary-materials-for-cell-and-gene-therapy-manufacturing%3Futm_medium%3Dsocial%26utm_source%3Demail)

![WhiteTwoLine](https://go.technologynetworks.com/hubfs/WhiteTwoLine.png "WhiteTwoLine")

 

Technology Networks Limited

Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK

[Email: privacy@technologynetworks.com](mailto:privacy@technologynetworks.com?Subject=Privacy)

© 2021 Technology Networks, All rights reserved

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)